Results 141 to 150 of about 951,374 (223)

A Systematic Review on Yellow Fever Vaccine and Adverse Events. [PDF]

Glob Health Epidemiol Genom
Santangelo OE, Pizzamiglio AS, Carlotta V.   +2 more
europepmc   +1 more source

New Insights Into an Old Vaccine: Potency and Breadth of Neutralizing Antibodies Elicited by Yellow Fever Vaccine 17D Are Boosted by Heterologous Orthoflavivirus Infection. [PDF]

J Infect Dis
Coulter FJ, Micheletti CA, Estrada AE, Luo S, Osman SR, Nix CD, Hu SY, Sampouw SM, Kareko BW, Naleway AL, Messer WB.   +10 more
europepmc   +1 more source

Acceptance of yellow fever vaccine in the older traveller: a cohort study. [PDF]

Acta Biomed, 2021
Ferrara P, Masuet-Aumatell C, Ramon-Torrell JM.   +2 more
europepmc   +1 more source

Yellow Fever Vaccine-Associated Viscerotropic Disease: A Unique Case of Atraumatic Splenic Rupture. [PDF]

Case Rep Infect Dis
Nortey E, Bediako EM, Mould GK, Mills-Annoh A, Ekremet K, Kyei-Baffour P, Ekem A, Clarke JCA, Apaloo EFEK, Quartey-Papafio S.   +9 more
europepmc   +1 more source

Yellow fever vaccine protects mice against Zika virus infection. [PDF]

PLoS Negl Trop Dis, 2021
Vicente Santos AC, Guedes-da-Silva FH, Dumard CH, Ferreira VNS, da Costa IPS, Machado RA, Barros-Aragão FGQ, Neris RLS, Dos-Santos JS, Assunção-Miranda I, Figueiredo CP, Dias AA, Gomes AMO, de Matos Guedes HL, Oliveira AC, Silva JL.   +15 more
europepmc   +1 more source

Effectiveness of the Local Additional Risk Minimisation Measures for Yellow Fever Vaccine in the United Kingdom: A Survey of Healthcare Professionals and Vaccinees. [PDF]

Pharmacoepidemiol Drug Saf
Karimi L, Luguzis A, Pawar N, Dufournet M, Morelli F, Thollot Y, Guichard MC, Petti G, Li L.   +8 more
europepmc   +1 more source

Anterograde transneuronal tracing and genetic control with engineered yellow fever vaccine YFV-17D. [PDF]

Nat Methods, 2021
Li E, Guo J, Oh SJ, Luo Y, Oliveros HC, Du W, Arano R, Kim Y, Chen YT, Eitson J, Lin DT, Li Y, Roberts T, Schoggins JW, Xu W.   +14 more
europepmc   +1 more source

Influence of obesity on susceptibility to systemic symptoms and host responses to orthoflaviviral infection: a prospective observational study using yellow fever vaccine to simulate acute infection. [PDF]

EBioMedicine
Syenina A, Tham CYL, Tng DJH, Chew VSY, Yee JX, Leong YS, Hamis NZ, Tan HC, Joon HY, Chan JT, Yang Y, Cheung YB, Ong EZ, Low JG, Ooi EE.   +14 more
europepmc   +1 more source

Immunogenicity and safety of primary fractional-dose yellow fever vaccine in autoimmune rheumatic diseases. [PDF]

PLoS Negl Trop Dis, 2021
Tonacio AC, do Nascimento Pedrosa T, Borba EF, Aikawa NE, Pasoto SG, Filho JCRF, Sampaio Barros MM, Leon EP, Lombardi SCFS, Junior AM, Azevedo AS, Schwarcz WD, Fuller R, Yuki EFN, Ugolini Lopes MR, Rodrigues Pereira RM, Sampaio Barros PD, de Andrade DCO, de Medeiros-Ribeiro AC, de Moraes JCB, Shinjo SK, Miossi R, da Silva Duarte AJ, Lopes MH, Kallás EG, Almeida da Silva CA, Bonfá E.   +26 more
europepmc   +1 more source

Public health role for fractional dosage of yellow fever vaccine. [PDF]

Lancet, 2021
Staples JE, Alvarez AR.
europepmc   +1 more source